Federal Official Gazette
On January 11th of this year, the Secretariat of Health (SS), published in the Federal Official Gazette (DOF), the cannabis regulation, which is aimed at the regulation, control, promotion and sanitary surveillance of raw materials, pharmacological derivatives and medicines of Cannabis, for production, research, manufacturing and medical purposes.
In this regard, the following stands out:
• PURPOSES: The actions regulated by this Regulation for Cannabis are those that have the following purposes:
- Primary production to supply manufacturing
- Research for health
- Pharmacological research
- Manufacture of pharmacological derivatives and medicines, and
- Doctors for the realization of diagnoses, preventive, therapeutic, rehabilitation and palliative care.
• INVESTIGATION Those interested in conducting the investigations referred to in this Chapter must obtain, from COFEPRIS, the authorization of the Investigation Protocol. Interested parties must submit their request in writing, attaching the following documentation and data:
- The amount of Raw Material, Pharmacological Derivatives or Cannabis Medicines
- The document that proves the origin of the material object of the Investigation Protocol;
- The document stating compliance with the Tested and Traceability, from the origin to the final disposal, in accordance with the provisions issued by the competent authority, and
- The Investigation Protocol.
Read full article (Spanish)